Latest News
- Corporate Lawsuits
Tuesday, August 29, 2017
FDA Greenlights Humira Biosim Cyltezo for Multiple Inflammatory Diseases
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim Pharmaceuticals, Inc.’s Cyltezo™, a biosimilar to Humira®, in a pre-filled syringe for the treatment of multip…
Read the full story
Monday, August 07, 2017
Environmental Groups Sue FDA to Take Formaldehyde Out of Salons
The Environmental Working Group (EWG) and Women’s Voices for the Earth (WVE) are suing the Food and Drug Administration (FDA) because of the group’s failure to act on dangerous hair straig…
Read the full storyMonday, July 17, 2017
Patent Challenge Filed for Generic Version Of Soolantra Cream
Perrigo Company plc's subsidiary has filed a Paragraph IV Abbreviated New Drug Application with the FDA for a generic version of Soolantra® (ivermectin) cream, 1%. Following notification fr…
Read the full storyThursday, November 17, 2016
US Attorney Announces Charges Against Two Executives Tied to Philidor Pharmacy Scheme
The US Attorney’s Office, Southern District of New York has charged two executives in connection with the Philidor Pharmacy scheme that instigated a stock value plunge at Valeant when it was rev…
Read the full storyMonday, January 18, 2016
Class-Action Suit Against EOS Lip Balm Grows
With their colorful egg-shaped containers, palatable price points ($2.99) and assorted fruity and sweet scents, EOS (which stands for Evolution of Smooth) lip balms have been flying off of store shelv…
Read the full storyMonday, August 10, 2015
Court Rules in Favor of Amarin Corp. in "Off-label" Dispute
Amarin Corporation plc (NASDAQ: AMRN) today announced a United States District Court has ruled that Amarin may promote to healthcare professionals certain uses of Am…
Read the full storyTuesday, December 17, 2013
Cynosure Announces Successful Settlement of Patent Infringement Lawsuits
Cynosure, Inc. will receive $10 million plus future royalty payments under a comprehensive settlement agreement with Tria Beauty, Inc. that ends the patent infringement litigation between Tria and P…
Read the full storyTuesday, December 04, 2012
Court: Off-label Drug Promotion Is Protected Speech
The 2nd US Circuit Court of Appeals in New York voted 2-1 to overturn a pharmaceutical salesman's conviction for off-label drug marketing, citing violations against his free speech rights under the Fi…
Read the full storyTuesday, October 09, 2012
Revance Regains Rights to Its Botulinum Toxins
Revance Therapeutics, Inc. announced a settlement and termination agreement for its contractual relationships with Medicis Pharmaceutical Corporation concerning RT001 Botulinum Toxin Type A Topical Ge…
Read the full storyFriday, September 28, 2012
Pharma Penalties Total $10.2B Over Two Years
Pharmaceutical manufacturers have reached a total of 74 settlements, totaling $10.2 billion in financial penalties with federal and state governments between November 2, 2010 and July 18, 2012. That's…
Read the full storyWednesday, May 02, 2012
Mylan, Impax Win Ruling in Doryx Generics Patent Case
Mylan Inc. (MYL) said it began selling a generic version of the antibiotic Doryx today after a judge ruled it didn’t infringe a patent held by Warner Chilcott (WCRX) Plc.
Read the full story
